Study Shows Microneedle Patch Influenza Vaccine is Effective
and Painless
|
| |
|
In this Issue |
|
|
| • |
IVIG/Albumin Supply Index |
| • |
Open Market Pricing |
| • |
New Products from FFF |
| • |
Current Medicare
IVIG / SCIG Rates |
| • |
Resources |
| • |
Subscribe to IG Living and BioSupply Trends Quarterly |
|
|
|
|
|
|
| |
A new study shows that microneedle patches provide an alternative to conventional needle-and-syringe immunization, potentially offering improved immunogenicity, simplicity, cost-effectiveness, acceptability and safety. [ read more ] |
|
Clinical Trial of Universal Flu Vaccine Is a Success
Scientists at the National Institutes of Health (NIH), Frederick National Laboratory for Cancer Research and the University of Melbourne in Australia tested a new universal flu vaccine that produced good immunity against several different strains of influenza viruses. |
|
Coagadex Prevents or Reduces Bleeding in Children with Hereditary Factor X Deficiency
A Phase III study, known as TENO2, conducted in children 12 years and younger with a diagnosis of moderate or severe congenital factor X deficiency and either a history of severe bleeding or an F10 gene mutation causing a documented severe bleeding type, found that Coagadex was effective in preventing bleeding episodes and was well-tolerated and safe.
[ read more ]
|
|
|
